COMP <GO>
BLLN vs UNH // REVENUE GROWTH (YOY)
BillionToOne Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: BLLN 4
— UNH 9
▲ REVENUE GROWTH (YOY) LEADER: BLLN
LAST: $110.41 (-2.57%) • MKT CAP: $5.21B
revenue-growth
100.00%
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
revenue-growth
3.33%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BLLN VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BLLN | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 68.30% | 88.31% | -20.01 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.90% | 12.38% | -9.48 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | 15.3x | +79.73 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 0.29% | 6.25% | -5.96 | UNH | /fcf-yield <GO> |
| Operating Margin | 5.30% | 5.32% | -0.02 | UNH | /operating-margins <GO> |
| Net Profit Margin | 2.40% | 3.53% | -1.13 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 100.00% | 3.33% | +96.67 | BLLN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 22.24 | 3.09 | +19.15 | BLLN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | BLLN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.3 | 55.1 | -1.80 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 0.33 | +0.69 | BLLN | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.21B | $359.43B | -$354.22B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BLLN REV | UNH REV | BLLN GROSS % | UNH GROSS % | BLLN FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $305.1M | $447.57B | 68.3% | 88.7% | $15.7M | $16.07B |
| FY 2024 | $152.6M | $400.28B | 53.0% | 88.3% | -$46.8M | $20.70B |
| FY 2023 | $71.7M | $371.62B | — | 89.6% | -$56.9M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BLLN // BETA 1.02
UNH // BETA 0.33